News
BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...
Turkish scientists say that Pfizer's COVID-19 vaccine can increase the risk of eye damage, causing vision loss. A new study ...
7d
Health and Me on MSNPfizer COVID-19 Vaccine Linked To Major Eye Dysfunction, Study Finds
A new study suggests a potential link between the Pfizer COVID-19 vaccine and serious eye conditions like retinal vascular ...
The results revealed that taking both doses of Pfizer's COVID-19 vaccine led to fewer endothelial cells in the eye and ...
6d
TheHealthSite on MSNPfizer-BioNTech's COVID-19 Vaccine: What Does A Thicker Cornea And Reduced Cell Density Mean?
BioNTech's COVID-19 vaccine on one's eye, which could lead an indivual to permanent vision loss. Read on... TheHealthSite.com ...
14d
The Hearty Soul on MSNFather Shares Experience of Illness Following Pfizer COVID Vaccine, Discusses Recovery
According to Pfizer, "Hundreds of millions of doses of the Pfizer-BioNTech COVID-19 vaccine have been administered globally, and the benefit-risk profile of the vaccine remains positive for all ...
Scientists in Turkey found that the Pfizer COVID-19 vaccine impacted some people's corneas, according to a study.
A Turkish study finds Pfizer’s COVID-19 vaccine may cause temporary changes in corneal thickness and cell count, raising concerns for those with existing eye issues or transplants.
Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that the European Medicines Agency's (EMA) Committee for ...
The FDA has updated its warnings about potential cardiac risks associated with Pfizer and Moderna COVID-19 vaccines, particularly focusing on young men. Discover essential information about the latest ...
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company delayed the results of COVID-19 vaccine trials to influence the 2020 election.
An FDA review states that the benefits of Pfizer’s COVID-19 vaccine in kids ages 5 to 11 outweigh the potential risks, The Washington Post reported. The FDA noted in its review, released Oct. 22 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results